Dr. Liu is Professor of Statistics and Operations Research and Professor of Biostatistics, Carolina Center for Genome Sciences at the University of North Carolina at Chapel Hill. He received is PhD in Statistics from Ohio State University in 2004. Dr. Liu's current research interests include high dimensional data analysis, machine learning, nonparametric statistics, bioinformatics, and cancer genomics.

Dr. Lin is Dennis Gillings Distinguished Professor of Biostatistics and Member of the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill. Dr. Lin is an internationally-recognized leader in survival analysis and statistical genetics with 20 years of experience in cancer research, currently focused on pharmacogenomics in cancer.

Dr. Carpenter is Associate Professor of Health Policy and Management at the University of North Carolina at Chapel Hill. He received his PhD in Health Policy and Administration from the University of North Carolina at Chapel Hill in 2004. Dr. Carpenter's current research interests include cancer prevention and control, racial Health Disparities, cancer care quality and outcomes, cancer Clinical Trials, organization design and behavior, diffusion of innovations, and translating research into practice.

Dr. Cai is Cary C. Boshamer Distinguished Professor and Vice Chair of Biostatistics at the University of North Carolina at Chapel Hill. Dr. Cai is Co-Director of the Biostatistics Service of North Carolina Translational and Clinical Sciences Institute at the University of North Carolina at Chapel Hill and directs the methodology component within that service. Her expertise is in design and analysis of clinical trials and observational studies, longitudinal and survival data analysis, analysis of correlated responses, and missing data/measurement error methods.

Dr. Auman is Director, Tissue Procurement Facility and Research Assistant Professor in the Institute for Pharmacogenomics and Individualized Therapy at the University of North Carolina at Chapel Hill. He received his PhD in Pharmacology and Toxicology from Duke University in 2002. Dr. Auman's research interests include gene expression profiling to understand drug response in colorectal cancers.

Dr. Luckett is a statistician helping researchers use data to advance medical science. With expertise in machine learning, big data, and data science, he has collaborated with clinicians and scientists while pursuing his own research in statistical methods for personalized medicine. Dr. Luckett completed a PhD in biostatistics from the University of North Carolina at Chapel Hill in May of 2018.